阿柏西普
医学
眼科
黄斑变性
荧光血管造影
脉络膜新生血管
外科
贝伐单抗
视力
化疗
作者
Alexandros Rouvas,Panagiotis Theodossiadis,Ilias Georgalas,Nikolaos Gouliopoulos
出处
期刊:Retinal Cases & Brief Reports
[Ovid Technologies (Wolters Kluwer)]
日期:2023-11-07
标识
DOI:10.1097/icb.0000000000001515
摘要
Abstract Purpose: To present a case of a patient with bilateral wet age-related macular degeneration (AMD) who was unilaterally treated with intravitreal aflibercept injections (IAIs) and the disease status in the fellow eye ameliorated after an IAI. Methods: Retrospective case report. Results: A 72-year-old woman was diagnosed with wet and dry AMD in her right (OD) and left (OS) eye, respectively. In OD, treatment strategy comprised 3 monthly IAIs, followed by re-injections according-to-need, while optical coherence tomography (OCT) scans were performed before IAIs. One month after the second IAI, subretinal fluid developed in OS. One week later, an IAI was applied in OD; two days later the disease status in OS was assessed by fluorescein angiography and OCT. Surprisingly, in OS subretinal fluid completely resolved and fluorescein angiography did not detect leakage, highlighting the absence of an active choroidal neovascularization. The short interval between IAI and the resolution of exudative phenomena in the other eye is suggestive of a beneficial effect in the contralateral eye. Conclusion: Herein we showed that an IAI had an effect to the fellow untreated eye. Our observation is consistent with active aflibercept in the systemic circulation. To the best of our knowledge, no other report in literature has demonstrated this effect of aflibercept in wet AMD.
科研通智能强力驱动
Strongly Powered by AbleSci AI